Abstract
Chronic lymphocytic leukemia cells resist fasting-mimicking diet by inducing proteasome activation to escape starvation, which can be targeted using proteasome inhibition by bortezomib treatment to impede leukemia progression and prolong survival.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have